NCT06342999View on ClinicalTrials.gov

Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome

NAEnrolling by invitationINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

July 31, 2036

Study Completion Date

July 31, 2036

Conditions
Hypoplastic Left Heart Syndrome
Interventions
PROCEDURE

Fetal Aortic Valvuloplasty Procedure

Treatment given during pregnancy in which a balloon is used to increase the size of the baby's aortic valve in vitro.

DEVICE

Emerge Monorail and Over-The-Wire PTCA Dilatation Catheter

Balloon Catheter

DEVICE

Trek RX and Mini Trek RX Coronary Dilatation Catheter

Coronary Dilation Catheter

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

All Listed Sponsors
lead

Mauro H. Schenone

OTHER

NCT06342999 - Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome | Biotech Hunter | Biotech Hunter